CTRI/2017/12/010957
Not yet recruiting
Phase 2
A Clinical Study to Evaluate the Efficacy and Safety of Marham-e-Safeda Kafoori in the Management of Nar Farsi (Eczema)
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Central Research Institute of Unani Medicine
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients of any sex in the age group of 18 to 65 years
- •2\. Patients having the following symptoms:
- •3\. Erythema
- •4\. Scaling
- •5\. Lichenification
- •6\. Excoriation
- •Hyperpigmentation
- •Burnig Sensation
Exclusion Criteria
- •1\. Patients aged below 18 years and above 65 years
- •2\. Patients on concomitant therapy
- •3\. Co\-morbid patient
- •4\. Patients suffering from: Diabetes mellitus, Hypertension
- •5\. Pregnant and Lactating women
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
A Clinical Study to Evaluate the Efficacy and Safety of JR-031 in Patients with Epidermolysis BullosaEpidermolysis BullosaJPRN-UMIN000026645Osaka University6
Recruiting
Not Applicable
Evaluation of the usefulness and safety of the combined use of an ear prosthesis and a cartilage conduction hearing aidJPRN-UMIN000044711Keio University30
Completed
Phase 2
Clinical comparative efficacy and safety of Polyherbal Unani formulations.Health Condition 1: K120- Recurrent oral aphthaeCTRI/2023/02/049696State Unani Medical College, himmatganj Prayagraj40
Not yet recruiting
Phase 2
Effectiveness of Unani Drugs in High Blood PressureCTRI/2017/12/011006Central Research Institute of Unani Medicine
Active, not recruiting
Not Applicable
Study Evaluating Rapamune® Maintenance RegimeRenal transplantationMedDRA version: 17.1Level: PTClassification code 10038533Term: Renal transplantSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]EUCTR2014-004101-33-Outside-EU/EEAWyeth Korea, Inc.79